Gland Pharma gets USFDA nod for Cangrelor for Injection

Gland Pharma will launch the product with its marketing partner on receipt of final approval.

66
USFDA
Picture: Pixabay

Last Updated on December 14, 2021 by The Health Master

Hyderabad: Gland Pharma Limited has recently received a tentative approval from the United States Food and Drug Administration (USFDA) for Cangrelor for Injection, 50 mg/vial Single-Dose Vials.

Gland Pharma believes that we are amongst one of the first to files for this product and may be eligible for 180 days of generic drug exclusivity,” the company said in a release.

Gland Pharma will launch the product with its marketing partner on receipt of final approval.

Gland Pharma, a generic injectable focused pharmaceutical company was established in 1978 in Hyderabad.

It has a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology and ophthalmic solutions.

Zydus Cadila gets USFDA nod for generic Schizophrenia drug

Alembic gets USFDA tentative nod for drug for high BP

Biocon gets USFDA nod for Mycophenolic Acid

Morepen gets USFDA nod for anti-allergy drug

USFDA approves new drug to help identify cancer lesions

USFDA grants accelerated approval for Vosoritide for injection

ICMR designs kit to detect new variant Omicron in 2 hours

Inquiry needed into unfair trade practice of discount pricing by Medical…

Marksans Pharma gets UK MHRA nod for Diarrhoea medication

Zydus Cadila gets USFDA nod for generic Schizophrenia drug

High Court quashed the criminal complaint of alleged NSQ drug

Medical treatments may get more expensive for you from next year

Increase in Pharmacy colleges to meet rising demand of Medical Stores

IPC flags safety alert against NSAID Diclofenac

Procedure for registration of Medical Devices: CDSCO

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner